Crinetics Pharmaceuticals, Inc.·5

Feb 12, 5:25 PM ET

Krasner Alan Seth 5

5 · Crinetics Pharmaceuticals, Inc. · Filed Feb 12, 2019

Insider Transaction Report

Form 5
Period: 2018-12-31
Krasner Alan Seth
Chief Medical Officer
Transactions
  • Other

    Common Stock

    2018-11-20$14.45/sh+1,470$21,2423,470 total
Footnotes (1)
  • [F1]Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

Documents

1 file
  • 5
    doc5.xmlPrimary

    FORM 5 SUBMISSION